Obesity and diabetes are two of the most common health issues, and they’re closely connected. Studies show that around 80 ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...

Sugar, once the shining "white gold" of global trade, now stands at the heart of one of the biggest health challenges worldwide. It has become the key driver of obesity, diabetes, heart diseases, ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Copenhagen, Denmark Saturday, April 26, 2025, 18:00 Hrs [IST] ...